Stockreport

Repare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023 [Yahoo! Finance]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF Net Loss : Increased net loss to $28.0 million in Q4 and $93.8 million for the full year. Research and Development Expenses : R&D expenses rose to $35.3 million in Q4 [Read more]